Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Cocco

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
Journal of Neuroimmunology|June 25, 2023
Leukocyte telomere length in women with multiple sclerosis: Comparison with healthy women during pregnancy and puerperiumP Caria, S Pilotto, M N D'Alterio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2013
Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical featuresJ Frau, D Cossu, G Coghe, et al.
Neurology|September 15, 2004
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional studyC Solaro, G Brichetto, M P Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2013
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosisA Ghezzi, P Annovazzi, M P Amato, et al.
Human Molecular Genetics|December 14, 2001
Dissection of the HLA association with multiple sclerosis in the founder isolated population of SardiniaM G Marrosu, R Murru, M R Murru, et al.
British Journal of Cancer|April 26, 2012
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapyS Bellone, D Roque, E Cocco, et al.
British Journal of Cancer|September 15, 2011
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumabP Todeschini, E Cocco, S Bellone, et al.
Multiple Sclerosis and Related Disorders|November 14, 2017
Brain volume in early MS patients with and without IgG oligoclonal bands in CSFG Fenu, L Lorefice, V Sechi, et al.
British Journal of Cancer|October 1, 2014
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivoC L Schwab, S Bellone, D P English, et al.
British Journal of Cancer|August 12, 2010
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinomaE Cocco, Z Hu, C E Richter, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
Journal of Neuroimmunology|June 25, 2023
Leukocyte telomere length in women with multiple sclerosis: Comparison with healthy women during pregnancy and puerperiumP Caria, S Pilotto, M N D'Alterio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 27, 2013
Mycobacterium avium subsp. paratuberculosis and multiple sclerosis in Sardinian patients: epidemiology and clinical featuresJ Frau, D Cossu, G Coghe, et al.
Neurology|September 15, 2004
The prevalence of pain in multiple sclerosis: a multicenter cross-sectional studyC Solaro, G Brichetto, M P Amato, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|February 6, 2013
Adverse events after endovascular treatment of chronic cerebro-spinal venous insufficiency (CCSVI) in patients with multiple sclerosisA Ghezzi, P Annovazzi, M P Amato, et al.
Human Molecular Genetics|December 14, 2001
Dissection of the HLA association with multiple sclerosis in the founder isolated population of SardiniaM G Marrosu, R Murru, M R Murru, et al.
British Journal of Cancer|April 26, 2012
Downregulation of membrane complement inhibitors CD55 and CD59 by siRNA sensitises uterine serous carcinoma overexpressing Her2/neu to complement and antibody-dependent cell cytotoxicity in vitro: implications for trastuzumab-based immunotherapyS Bellone, D Roque, E Cocco, et al.
British Journal of Cancer|September 15, 2011
Her2/neu extracellular domain shedding in uterine serous carcinoma: implications for immunotherapy with trastuzumabP Todeschini, E Cocco, S Bellone, et al.
Multiple Sclerosis and Related Disorders|November 14, 2017
Brain volume in early MS patients with and without IgG oligoclonal bands in CSFG Fenu, L Lorefice, V Sechi, et al.
British Journal of Cancer|October 1, 2014
Afatinib demonstrates remarkable activity against HER2-amplified uterine serous endometrial cancer in vitro and in vivoC L Schwab, S Bellone, D P English, et al.
British Journal of Cancer|August 12, 2010
hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor for immunotherapy of uterine serous papillary carcinomaE Cocco, Z Hu, C E Richter, et al.
Pageof 14